Clonegene (@Clonegene) header
Clonegene (@Clonegene) profile picture

Clonegene produces biomedical reagents including monoclonal antibodies, bispecific antibodies diagnostic antigens, cancer neoantigens and RNA vaccines.

CT, USA
Joined July 2009
RNA promotes the formation of spatial compartments in the nucleus sciencedirect.com/science/ar…
1
Genome-wide functional screen of 3′UTR variants uncovers causal variants for human disease and evolution cell.com/cell/fulltext/S0092…
1
2
A useful educational exercise, using SARS-COV-2 as a device to teach Bioinformatics teacherspayteachers.com/Prod…
1
1
2
Clonegene retweeted
The sad tale of Ms. Haversham and SARS-COV-2. But an excellent educational lab exercise ! teacherspayteachers.com/Prod…
A human apolipoprotein L with detergent-like activity kills intracellular pathogens science.sciencemag.org/conte…
2
Transmission, infectivity, and neutralization of a spike L452R SARS-CoV-2 variant cell.com/cell/fulltext/S0092…
1
1
Reducing acetylated tau is neuroprotective in brain injury cell.com/cell/fulltext/S0092…
1
Antibody evasion by the P.1 strain of SARS-CoV-2 cell.com/cell/fulltext/S0092…
Clonegene retweeted
Two new publications from the Steitz Lab reveal new forms of RNA-RNA interactions. Read more about these discoveries here: mbb.yale.edu/news/two-new-pu…
SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies cell.com/cell/fulltext/S0092…
Had guests for dinner. Wanted to make sure their vaccines had kicked in. This is 13 days after first Moderna shot.
20
14
2
144
We know your conference is virtual, but you still have to fill out a travel form to get reimbursed for the registration.
20
108
58
1,162
SARS-CoV-2 evolution during treatment of chronic infection ow.ly/ebua30rvM6F
Nearly 50% of all new Covid-19 cases in southern California in January are attributable to the new SARS-CoV-2 homegrown variant: CAL.20C. It appears to be far more infectious than previous strains has already begun to spread to other states and countries. news.sky.com/story/covid-19-…
6
17
3
24